Influenza viruses: Breaking all the rules

mBio

Volumn 4, Issue 4, 2013, Pages

  Taubenberger, Jeffery K ^a   Morens, David M ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; NONSTRUCTURAL PROTEIN 1; OSELTAMIVIR; PERAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

ANTIVIRAL RESISTANCE; ARTICLE; BIOSAFETY; CYTOKINE RESPONSE; DISEASE RE-EMERGENCE; GENETIC REASSORTMENT; HOST RANGE; HUMAN; IMMUNE EVASION; INFLUENZA A; INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N9; INFLUENZA VIRUS A H9N2; MIXED INFECTION; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEASONAL VARIATION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; ZOONOSIS;

AVES; INFLUENZA A VIRUS; MAMMALIA; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 84883401860     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00365-13     Document Type: Article

References (99)

1. Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p 1647-1690. In Knipe DM, Howley PM (ed), Fields virology, vol 2, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Wright PF, Neumann G, Kawaoka Y. 2007. Orthomyxoviruses, p 1691-1740. In Knipe DM, Howley PM (ed), Fields virology, vol 2, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Dugan VG, Chen R, Spiro DJ, Sengamalay N, Zaborsky J, Ghedin E, Nolting J, Swayne DE, Runstadler JA, Happ GM, Senne DA, Wang R, Slemons RD, Holmes EC, Taubenberger JK. 2008. The evolutionary genetics and emergence of avian influenza viruses in wild birds. PLoS Pathog. 4:e1000076. doi: 10.1371/journal.ppat.1000076.
4. Taubenberger JK, Kash JC. 2010. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7:440-451.
5. Guan Y, Poon LL, Cheung CY, Ellis TM, Lim W, Lipatov AS, Chan KH, Sturm-Ramirez KM, Cheung CL, Leung YH, Yuen KY, Webster RG, Peiris JS. 2004. H5N1 influenza: a protean pandemic threat. Proc. Natl. Acad. Sci. U. S. A. 101:8156-8161.
6. Peiris JS, de Jong MD, Guan Y. 2007. Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev. 20:243-267.
7. WHO. 2013. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported toWHO,2003-2013. http://www.who.int/influenza /human_animal_interface/EN_GIP_20130604CumulativeNumberH5N1 cases.pdf.
8. WHO. 2013. Number of confirmed human cases of avian influenza A(H7N9) reported to WHO. http://www.who.int/influenza/human _animal_interface/influenza_h7n9/08_ReportWebH7N9Number.pdf.
9. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, Neumann G, Saito T, Kawaoka Y, Tashiro M. 2013. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill. 18:20453.
10. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Zhang Y, Chan KH, Tsoi HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li L, Yuen KY. 2013. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381: 1916-1925.
11. Morens DM, Taubenberger JK, Fauci AS. 2013. Pandemic influenza viruses-hoping for the road not taken. N. Engl. J. Med. 368:2345-2348.
12. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541.
13. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-428.
14. Morens DM, Subbarao K, Taubenberger JK. 2012. Engineering H5N1 avian influenza viruses to study human adaptation. Nature 486:335-340.
15. Fouchier R, Osterhaus AB, Steinbruner J, Yuen KY, Henderson DA, Klotz L, Sylvester E, Taubenberger JK, Ebright RH, Heymann DL. 2012. Preventing pandemics: the fight over flu. Nature 481:257-259.
16. Zhang Y, Zhang Q, Kong H, Jiang Y, Gao Y, Deng G, Shi J, Tian G, Liu L, Liu J. 2013. H5N1 hybrid viruses bearing 2009/H1N1 virs genes transmit in guinea pigs by respiratory droplet. Science 340:1459-1463.
17. Perez DR. 2012. Public health and biosecurity. H5N1 debates: hung up on the wrong questions. Science 335:799-801.
18. Office of Biotechnology Activities NIH. 2012. U.S. government policy for oversight of life sciences dual use research of concern. http://www.phe.gov/s3/dualuse/Documents/us-policy-durc-032812.pdf.
19. Alexander DJ, Brown IH. 2009. History of highly pathogenic avian influenza. Rev. Sci. Tech. 28:19-38.
20. Morens DM, Taubenberger JK. 2011. Pandemic influenza: certain uncertainties. Rev. Med. Virol. 21:262-284.
21. Morens DM, Taubenberger JK, Fauci AS. 2009. The persistent legacy of the 1918 influenza virus. N. Engl. J. Med. 361:225-229.
22. Miller MA, Viboud C, Balinska M, Simonsen L. 2009. The signature features of influenza pandemics-implications for policy. N. Engl. J. Med. 360:2595-2598.
23. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. 1998. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 178:53-60.
24. Thompson MG, Shay DK, Zhou H, Bridges CB, Cheng PY, Burns E, Bresee JS, Cox NJ. 2010. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWRMorb. Mortal. Wkly. Rep. 59:1057-1062.
25. CDC. 2004. 2003-2004 U.S. influenza season summary. http://www.cdc.gov/flu/weekly/weeklyarchives2003-2004/03-04summary.htm.
26. Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, St George K, Grenfell BT, Salzberg SL, Fraser CM, Lipman DJ, Taubenberger JK. 2005. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol. 3:e300. doi: 10.1371/journal.pbio.0030300.
27. Memoli MJ, Jagger BW, Dugan VG, Qi L, Jackson JP, Taubenberger JK. 2009. Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift. J. Infect. Dis. 200: 1232-1241.
28. García-Sastre A. 2011. Induction and evasion of type I interferon responses by influenza viruses. Virus Res. 162:12-18.
29. Hale BG, Randall RE, Ortín J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89:2359-2376.
30. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, García-Sastre A. 2002. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. U. S. A. 99:10736-10741.
31. Seo SH, Hoffmann E, Webster RG. 2002. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8:950-954.
32. Lipatov AS, Andreansky S, Webby RJ, Hulse DJ, Rehg JE, Krauss S, Perez DR, Doherty PC, Webster RG, Sangster MY. 2005. Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B-and T-cell responses. J. Gen. Virol. 86:1121-1130.
33. Jiao P, Tian G, Li Y, Deng G, Jiang Y, Liu C, Liu W, Bu Z, Kawaoka Y, Chen H. 2008. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J. Virol. 82:1146-1154.
34. McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, Mc-Cullers JA. 2010. PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog. 6:e1001014. doi: 10.1371/journal.ppat.1001014.
35. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. 2007. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3:1414-1421. doi: 10.1371/journal.ppat.0030141.
36. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA. 2007. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2:240-249.
37. Smith AM, McCullers JA. 14 March 2013. Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses. Virus Res. doi: 10.1016/j.virusres.2013.02.012. [Epub ahead of print.]
38. Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, Dunfee RL, Schwartzman LM, Ozinsky A, Bell GL, Dalton RM, Lo A, Efstathiou S, Atkins JF, Firth AE, Taubenberger JK, Digard P. 2012. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337:199-204.
39. Yewdell JW. 2011. Viva la revolucion: rethinking influenza A virus antigenic drift. Curr. Opin. Virol. 1:177-183.
40. Morens DM, Taubenberger JK, Fauci AS. 2010. The 2009 H1N1 pandemic influenza virus: what next? mBio 1:e00211-10. doi: 10.1128/ mBio.00211-10.
41. Fitch WM, Leiter JM, Li XQ, Palese P. 1991. Positive Darwinian evolution in human influenza A viruses. Proc. Natl. Acad. Sci. U. S. A. 88: 4270-4274.
42. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
43. Hayden FG. 2006. Antivirals for influenza: historical perspectives and lessons learned. Antiviral Res. 71:372-378.
44. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. 2006. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295:891-894.
45. Moscona A. 2009. Global transmission of oseltamivir-resistant influenza. N. Engl. J. Med. 360:953-956.
46. Bloom JD, Gong LI, Baltimore D. 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272-1275.
47. Krumbholz A, Schmidtke M, Bergmann S, Motzke S, Bauer K, Stech J, Dürrwald R, Wutzler P, Zell R. 2009. High prevalence of amantadine resistance among circulating European porcine influenza A viruses. J. Gen. Virol. 90:900-908.
48. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, et al. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
49. Renaud C, Kuypers J, Englund JA. 2011. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1. J. Clin. Virol. 52:70-78.
50. Samson M, Pizzorno A, Abed Y, Boivin G. 2013. Influenza virus resistance to neuraminidase inhibitors. Antiviral Res. 98:174-185.
51. Memoli MJ, Davis AS, Proudfoot K, Chertow DS, Hrabal RJ, Bristol T, Taubenberger JK. 2011. Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J. Infect. Dis. 203:348-357.
52. Memoli MJ, Hrabal RJ, Hassantoufighi A, Eichelberger MC, Taubenberger JK. 2010. Rapid selection of oseltamivir-and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin. Infect. Dis. 50:1252-1255.
53. Memoli MJ, Hrabal RJ, Hassantoufighi A, Jagger BW, Sheng ZM, Eichelberger MC, Taubenberger JK. 2010. Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host. J. Infect. Dis. 201:1397-1403.
54. de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J. 2005. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353:2667-2672.
55. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y. 2005. Avian flu: isolation of drugresistant H5N1 virus. Nature 437:1108.
56. Liu Q, Lu L, Sun Z, Chen GW, Wen Y, Jiang S. 2013. Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China. Microbes Infect. 15:432-439.
57. Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, Bi Y, Wu Y, Li X, Yan J, Liu W, Zhao G, Yang W, Wang Y, Ma J, Shu Y, Lei F, Gao GF. 2013. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 381:1926-1932.
58. Myers KP, Olsen CW, Gray GC. 2007. Cases of swine influenza in humans: a review of the literature. Clin. Infect. Dis. 44:1084-1088.
59. Lakdawala SS, Lamirande EW, Suguitan AL, Jr, Wang W, Santos CP, Vogel L, Matsuoka Y, Lindsley WG, Jin H, Subbarao K. 2011. Eurasianorigin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog. 7:e1002443. doi: 10.1371/journal.ppat.1002443.
60. Yen HL, Liang CH, Wu CY, Forrest HL, Ferguson A, Choy KT, Jones J, Wong DD, Cheung PP, Hsu CH, Li OT, Yuen KM, Chan RW, Poon LL, Chan MC, Nicholls JM, Krauss S, Wong CH, Guan Y, Webster RG, Webby RJ, Peiris M. 2011. Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc. Natl. Acad. Sci. U. S. A. 108:14264-14269.
61. Parrish CR, Holmes EC, Morens DM, Park EC, Burke DS, Calisher CH, Laughlin CA, Saif LJ, Daszak P. 2008. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol. Mol. Biol. Rev. 72:457-470.
62. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. 2005. Characterization of the 1918 influenza virus polymerase genes. Nature 437:889-893.
63. Scholtissek C, Rohde W, Von Hoyningen V, Rott R. 1978. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87: 13-20.
64. Kawaoka Y, Krauss S, Webster RG. 1989. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 63:4603-4608.
65. Dunham EJ, Dugan VG, Kaser EK, Perkins SE, Brown IH, Holmes EC, Taubenberger JK. 2009. Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J. Virol. 83: 5485-5494.
66. Pensaert M, Ottis K, Vandeputte J, Kaplan MM, Bachmann PA. 1981. Evidence for the natural transmission of influenzaAvirus from wild ducks to swine and its potential importance for man. Bull. World Health Organ. 59:75-78.
67. Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. 2001. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:1829-1839.
68. Shope RE. 1936. The incidence of neutralizing antibodies for swine influenza virus in the sera of human beings of different ages. J. Exp. Med. 63:669-684.
69. Brown IH. 2000. The epidemiology and evolution of influenza viruses in pigs. Vet. Microbiol. 74:29-46.
70. Guan Y, Shortridge KF, Krauss S, Li PH, Kawaoka Y, Webster RG. 1996. Emergence of avian H1N1 influenza viruses in pigs in China. J. Virol. 70:8041-8046.
71. Karasin AI, Brown IH, Carman S, Olsen CW. 2000. Isolation and characterization of H4N6 avian influenza viruses from pigs with pneumonia in Canada. J. Virol. 74:9322-9327.
72. Karasin AI, West K, Carman S, Olsen CW. 2004. Characterization of avian H3N3 and H1N1 influenza A viruses isolated from pigs in Canada. J. Clin. Microbiol. 42:4349-4354.
73. Ma W, Vincent AL, Gramer MR, Brockwell CB, Lager KM, Janke BH, Gauger PC, Patnayak DP, Webby RJ, Richt JA. 2007. Identification of H2N3 influenza A viruses from swine in the United States. Proc. Natl. Acad. Sci. U. S. A. 104:20949-20954.
74. Vincent A, Awada L, Brown I, Chen H, Claes F, Dauphin G, Donis R, Culhane M, Hamilton K, Lewis N, Mumford E, Nguyen T, Parchariyanon S, Pasick J, Pavade G, Pereda A, Peiris M, Saito T, Swenson S, Van Reeth K, Webby R, Wong F, Ciacci-Zanella J. 5 April 2013. Review of influenza A virus in swine worldwide: a call for increased surveillance and research. Zoonoses Public Health doi: 10.1111/zph.12049. [Epub ahead of print].
75. Zhou NN, Senne DA, Landgraf JS, Swenson SL, Erickson G, Rossow K, Liu L, Yoon Kj, Krauss S, Webster RG. 1999. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J. Virol. 73:8851-8856.
76. Barman S, Krylov PS, Fabrizio TP, Franks J, Turner JC, Seiler P, Wang D, Rehg JE, Erickson GA, Gramer M, Webster RG, Webby RJ. 2012. Pathogenicity and transmissibility of North American triple reassortant swine influenza A viruses in ferrets. PLoS Pathog. 8:e1002791. doi: 10.1371/journal.ppat.1002791.
77. Nelson MI, Detmer SE, Wentworth DE, Tan Y, Schwartzbard A, Halpin RA, Stockwell TB, Lin X, Vincent AL, Gramer MR, Holmes EC. 2012. Genomic reassortment of influenza A virus in North American swine, 1998-2011. J. Gen. Virol. 93:2584-2589.
78. Nelson MI, Gramer MR, Vincent AL, Holmes EC. 2012. Global transmission of influenza viruses from humans to swine. J. Gen. Virol. 93: 2195-2203.
79. CDC. 2012. Notes from the field: outbreak of influenza A (H3N2) virus among persons and swine at a county fair-Indiana, July 2012. MMWR Morb. Mortal. Wkly. Rep. 61:561.
80. Nelson MI, Vincent AL, Kitikoon P, Holmes EC, Gramer MR. 2012. Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011. J. Virol. 86:8872-8878.
81. Morens DM, Taubenberger JK. 2010. Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza Other Resp. Viruses 4:327-337.
82. Guo Y, Wang M, Kawaoka Y, Gorman O, Ito T, Saito T, Webster RG. 1992. Characterization of a new avian-like influenzaAvirus from horses in China. Virology 188:245-255.
83. Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, Chen L, Smith C, Hill RC, Ferro P, Pompey J, Bright RA, Medina MJ, Johnson CM, Olsen CW, Cox NJ, Klimov AI, Katz JM, Donis RO. 2005. Transmission of equine influenza virus to dogs. Science 310:482-485.
84. Song D, Kang B, Lee C, Jung K, Ha G, Kang D, Park S, Park B, Oh J. 2008. Transmission of avian influenza virus (H3N2) to dogs. Emerg. Infect. Dis. 14:741-746.
85. Shi M, Jagger BW, Wise HM, Digard P, Holmes EC, Taubenberger JK. 2012. Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus. J. Virol. 86:12411-12413.
86. Chertow DS. 2012. Contribution of bacterial coinfection to severe influenza infection. Crit. Care Med. 40:1664-1665.
87. Morens DM, Taubenberger JK, Fauci AS. 2008. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198:962-970.
88. García-Rodríguez JA, Fresnadillo Martínez MJ. 2002. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J. Antimicrob. Chemother. 50(Suppl. S2): 59-73.
89. Kluytmans JA, Wertheim HF. 2005. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 33:3-8.
90. Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL, Pneumococcal Carriage Group. 2012. The fundamental link between pneumococcal carriage and disease. Expert Rev. Vaccines 11:841-855.
91. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. 2005. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5:751-762.
92. Kash JC, Walters KA, Davis AS, Sandouk A, Schwartzman LM, Jagger BW, Chertow DS, Li Q, Kuestner RE, Ozinsky A, Taubenberger JK. 2011. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. mBio 2:e00172-11. doi: 10.1128/mBio.00172-11.
93. McCullers JA. 2006. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19:571-582.
94. Taubenberger JK, Hultin JV, Morens DM. 2007. Discovery and characterization of the 1918 pandemic influenza virus in historical context. Antivir. Ther. 12:581-591.
95. Taubenberger JK, Baltimore D, Doherty PC, Markel H, Morens DM, Webster RG, Wilson IA. 2012. Reconstruction of the 1918 influenza virus: unexpected rewards from the past. mBio 3:e00201-12. doi: 10.1128/ mBio.00201-12.
96. Viboud C, Eisenstein J, Reid AH, Janczewski TA, Morens DM, Taubenberger JK. 2013. Age-and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky. J. Infect. Dis. 207:721-729.
97. Dowdle WR. 2006. Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg. Infect. Dis. 12:34-39.
98. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361:1945-1952.
99. Patterson AP, Tabak LA, Fauci AS, Collins FS, Howard S. 2013. Research funding. A framework for decisions about research with HPAI H5N1 viruses. Science 339:1036-1037.